Abstract
Transcutaneous electrical nerve stimulation (TENS) is commonly used in clinical practice for alleviating pain and physiological disorders. It has been reported that TENS could counteract ischemic injury in vital organs. To determine the protective effect of TENS on internal organs during controlled hypotension (CH) in dogs, target hypotension was maintained for 60 min at 50% of the baseline mean arterial pressure (MAP). The perfusion to the brain, liver, stomach, and kidney was recorded, and apoptosis within these organs was observed. Results showed that during the maintenance stage, perfusion to the stomach and liver in the CH+TENS group was significantly higher than in the CH group (P<0.05). After withdrawing CH, gastric and cerebral cortical blood flow in the CH+TENS group increased rapidly. Furthermore, TENS significantly reduced the number of TUNEL-positive (apoptotic) cells in stomach and kidney tissue compared to the CH-only group. Our results demonstrate that TENS combined with general anesthesia (GA) can improve blood flow to the liver and stomach and reduce apoptosis in the stomach and kidney during hypotensive states.
Introduction
In major surgical procedures, controlled hypotension (CH) is a vital technique used to reduce blood loss and provide a clearer surgical field. By deliberately lowering a patient’s mean arterial pressure (MAP), surgeons can minimize hemorrhage. However, this reduction in systemic pressure carries the risk of "hypoperfusion," where vital organs do not receive adequate oxygenated blood. This can lead to ischemic injury and trigger apoptosis (programmed cell death), particularly in sensitive organs like the brain, liver, and kidneys.
This study investigates whether Transcutaneous Electrical Nerve Stimulation (TENS), a non-invasive method typically used for pain relief, can act as a protective intervention. The researchers aimed to determine if TENS could modulate blood flow redistribution to protect these "innocent bystander" organs during a significant 50% drop in MAP.
Methods
The study utilized a canine model consisting of 18 beagle dogs divided into three experimental groups:
- GA Group: General anesthesia only (control).
- CH Group: General anesthesia + controlled hypotension (MAP reduced to 50% of baseline for 60 minutes using sodium nitroprusside).
- CH+TENS Group: General anesthesia + controlled hypotension + TENS applied to four bilateral acupuncture points: Hegu (LI4), Zusanli (ST36), Sanyinjiao (SP6), and Quchi (LI11). Stimulation began 30 minutes before and continued throughout the hypotensive period.
Key Measurements: * Organ Perfusion: Real-time blood flow in the cerebral cortex, liver, kidney, and stomach was measured using Laser Doppler flowmetry at ten specific time points (T1–T10). * Apoptosis: 72 hours post-procedure, tissue samples from the hippocampus, liver, kidney, and stomach were analyzed using TUNEL staining to quantify programmed cell death.
Key Insights and Results
Selective Organ Vulnerability
The study revealed that organs react differently to hypotension. While the liver and hippocampus remained relatively resilient at a 50% MAP reduction, the stomach and kidneys showed a significant spike in apoptotic cells 72 hours after the procedure in the CH-only group.
TENS as a Circulatory Regulator
TENS intervention successfully buffered the drop in local blood flow. During the early maintenance of hypotension, the CH+TENS group maintained significantly higher blood flow in the stomach and liver compared to the CH group ($P < 0.05$). This suggests that TENS may modulate the autonomic nervous system or the endogenous opioid system to maintain organ perfusion.
Accelerated Recovery
A critical finding was the "recovery boost" provided by TENS. After the hypotensive period ended, TENS significantly accelerated the return of blood flow to the stomach and cerebral cortex. In contrast, gastric blood flow in the CH-only group remained low even after systemic blood pressure returned to baseline.
Inhibition of Cell Death
Most importantly, TENS effectively inhibited apoptosis. In the stomach and kidneys, where the CH group showed high levels of cell death, the CH+TENS group maintained apoptosis levels near those of the healthy GA control group.
Discussion and Limitations
While the study demonstrates the protective efficacy of TENS, several areas require further exploration:
- Mechanism Specificity: The exact neurochemical pathways (e.g., specific neurotransmitters) involved in this protective effect remain partially speculative.
- Clinical Translation: While beagle dogs are a standard cardiovascular model, human autonomic responses to TENS under anesthesia may vary.
- Pressure Thresholds: Future research should investigate the "breaking point" where TENS may no longer be sufficient to protect organs at MAP reductions greater than 50%.
- Long-term Outcomes: Apoptosis was measured at 72 hours; longer-term studies are needed to confirm if these cellular protections translate into improved clinical organ function weeks after surgery.
In conclusion, TENS combined with general anesthesia represents a promising, non-invasive strategy to improve organ perfusion and reduce ischemic damage during surgeries requiring controlled hypotension.
Summary updated